Form 8-K - Current report:
SEC Accession No. 0001104659-24-071747
Filing Date
2024-06-14
Accepted
2024-06-14 16:05:28
Documents
13
Period of Report
2024-06-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2417162d1_8k.htm   iXBRL 8-K 22757
  Complete submission text file 0001104659-24-071747.txt   188037

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA enzn-20240610.xsd EX-101.SCH 3006
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20240610_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20240610_pre.xml EX-101.PRE 22353
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2417162d1_8k_htm.xml XML 3247
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12957 | Film No.: 241044704
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)